Research from Harvard Medical School Provides New Data on Mucopolysaccharidoses (Intravenous Idursulfase for the Treatment of Mucopolysaccharidosis Type II: A Systematic Literature Review).

MLA

“Research from Harvard Medical School Provides New Data on Mucopolysaccharidoses (Intravenous Idursulfase for the Treatment of Mucopolysaccharidosis Type II: A Systematic Literature Review).” Drug Week, Aug. 2024, p. 2035. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=179225384&authtype=sso&custid=ns315887.

APA

Research from Harvard Medical School Provides New Data on Mucopolysaccharidoses (Intravenous Idursulfase for the Treatment of Mucopolysaccharidosis Type II: A Systematic Literature Review). (2024). Drug Week, 2035.

Chicago

“Research from Harvard Medical School Provides New Data on Mucopolysaccharidoses (Intravenous Idursulfase for the Treatment of Mucopolysaccharidosis Type II: A Systematic Literature Review).” 2024. Drug Week, August, 2035. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=179225384&authtype=sso&custid=ns315887.